Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Loss of BRCA1 Spontaneously Induces the Tumorigenesis in Lacrimal Gland.

Kim SE, Baek HJ, Park EJ, Lim SC, Kim SS.

Anal Cell Pathol (Amst). 2018 Dec 17;2018:8120579. doi: 10.1155/2018/8120579. eCollection 2018.

2.

Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach.

Cao L, Xu X, Cao LL, Wang RH, Coumoul X, Kim SS, Deng CX.

Carcinogenesis. 2007 Jul;28(7):1401-7. Epub 2007 Mar 15.

PMID:
17363841
3.

Tumor formation in Brca1 conditional mutant mice.

Deng CX.

Environ Mol Mutagen. 2002;39(2-3):171-7. Review.

PMID:
11921186
4.

Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.

Hoshino A, Yee CJ, Campbell M, Woltjer RL, Townsend RL, van der Meer R, Shyr Y, Holt JT, Moses HL, Jensen RA.

Int J Biol Sci. 2007 Apr 25;3(5):281-91.

5.

Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.

van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.

BMC Cancer. 2006 Mar 14;6:58.

6.

Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.

Brodie SG, Xu X, Qiao W, Li WM, Cao L, Deng CX.

Oncogene. 2001 Nov 8;20(51):7514-23.

8.
9.

Effect of bilateral oophorectomy on mammary tumor formation in BRCA1 mutant mice.

Bachelier R, Xu X, Li C, Qiao W, Furth PA, Lubet RA, Deng CX.

Oncol Rep. 2005 Nov;14(5):1117-20.

PMID:
16211273
10.

Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.

Bowen TJ, Yakushiji H, Montagna C, Jain S, Ried T, Wynshaw-Boris A.

Cancer Res. 2005 Oct 1;65(19):8736-46.

11.

Inhibition of Estrogen Signaling Reduces the Incidence of BRCA1-associated Mammary Tumor Formation.

Baek HJ, Kim SE, Choi EK, Kim JK, Shin DH, Park EJ, Kim TH, Kim JY, Kim KG, Deng CX, Kim SS.

Int J Biol Sci. 2018 Oct 3;14(12):1755-1768. doi: 10.7150/ijbs.28142. eCollection 2018.

12.

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX.

Nat Genet. 2001 Jul;28(3):266-71.

PMID:
11431698
13.

p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.

Scott A, Bai F, Chan HL, Liu S, Ma J, Slingerland JM, Robbins DJ, Capobianco AJ, Pei XH.

Oncotarget. 2016 Dec 20;7(51):84496-84507. doi: 10.18632/oncotarget.13015.

14.

Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.

McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.

Oncogene. 1998 May 28;16(21):2755-66.

15.
16.

Inhibition of AKT suppresses the initiation and progression of BRCA1-associated mammary tumors.

Baek HJ, Kim SE, Kim JK, Shin DH, Kim TH, Kim KG, Deng CX, Kim SS.

Int J Biol Sci. 2018 Oct 3;14(13):1769-1781. doi: 10.7150/ijbs.29242. eCollection 2018.

17.

Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.

Jones LP, Li M, Halama ED, Ma Y, Lubet R, Grubbs CJ, Deng CX, Rosen EM, Furth PA.

Oncogene. 2005 May 19;24(22):3554-62.

PMID:
15750629
18.

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.

Jamerson MH, Johnson MD, Korsmeyer SJ, Furth PA, Dickson RB.

Br J Cancer. 2004 Oct 4;91(7):1372-9.

19.

Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.

Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A.

Cancer Res. 2006 Jun 1;66(11):5565-73. Erratum in: Cancer Res. 2006 Jul 1;66(13):6894. Lozach, Laure Escoubet [corrected to Escoubet-Lozach, Laure]; Bassett, Ivan Garcia [corrected to Garcia-Bassets, Ivan].

20.

Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.

Wagh PK, Zinser GM, Gray JK, Shrestha A, Waltz SE.

Endocrinology. 2012 Jun;153(6):2735-46. doi: 10.1210/en.2011-1543. Epub 2012 Apr 2.

Supplemental Content

Support Center